In 2020, the European interventional cardiology market size was valued at approximately €928 million, down from nearly €1.2 billion in 2019 due to the impact of COVID-19. The European market size is expected to decrease over the forecast period and reach €1 billion in 2026. Over 50% of the European interventional cardiology market share was
In 2020, the global interventional cardiology market size was valued at approximately $11.1 billion, down from nearly $14 billion in 2019 due to the impact of COVID-19. The global market size is expected to reach an astonishing $16.2 billion in 2027. Over 40% of the global interventional cardiology market share was controlled by Boston Scientific,
Thrombectomy is the process by which an intravascular catheter is used to remove or aspirate obstructing particles from the bloodstream. Thrombosis is a disease state that occurs when dislodged blood clots or thrombi block the normal flow of blood through a vessel, causing complications, such as myocardial infarction or stroke. Most thrombi are produced when vulnerable plaque ruptures and the fragments are released into the bloodstream. The intravascular coagulation of blood cells is primarily responsible for the development of thrombi.
The full report suite on the Japanese market for interventional cardiology includes analysis on the coronary stent, coronary balloon catheter, balloon-inflation device, interventional coronary catheter, interventional coronary guidewire, introducer sheath, coronary vascular closure device, diagnostic coronary catheter and guidewire, fractional flow reserve (FFR) guidewire, intravascular ultrasound (IVUS) catheter, and optical coherence tomography (OCT) catheter markets.